April 25, 2024 | ePaper | SignIn

Health

ICMR bats for Oxford vaccine, WHO lists 3 more as frontrunners

New Delhi, April 19 (IANS) The Indian Council of Medical Research (ICMR) on Sunday said that a candidate vaccine called ChAdOX1 a" being developed...

Why you need to use ACs with caution during COVID-19

New Delhi, April 19 (IANS) Rumors spread on the Internet suggest that use of air conditioners during this summer may not be safe as...

Covid-19 changes medication needs of masses

New Delhi, April 18 (IANS) The novel coronavirus pandemic has brought about a sudden change in the medication needs of masses with a clear...

Dow futures up after Gilead’s drug shows promise against COVID-19

New York, April 17 (IANS) A potential drug from pharmaceutical major Gilead Sciences has shown tremendous promise in an ongoing clinical trial at the...

ICU doctors should use double layer protection to prevent COVID-19: Experts

New Delhi, April 17 (IANS) Since the COVID-19 crisis has gripped India, reports of doctors' deaths due to coronavirus has remained a major concern...

Paracetamol consumption in India has not gone up in last 1 month: Experts

BY SUMIT SAXENA New Delhi, April 17 (IANS) The consumption of paracetamol has not increased in the past one month nor is there an...

Are smokers at greater risk of contracting COVID-19?

BY SIDDHI JAIN New Delhi, April 16 (IANS) Are smokers, in particular, at any higher risk of getting infected? Health experts say yes. Although the...

Sanofi, GlaxoSmithKline join hands to speed up COVID-19 vaccine

London, April 14 (IANS) Pharmaceutical giants Sanofi and GlaxoSmithKline (GSK) on Tuesday joined hands to speed up and develop an adjuvanted vaccine for COVID-19...

Arthritis and coronavirus: All you need to know

New Delhi, April 13 (IANS) Older people are more prone to novel Covid-19, owing to their underlying health conditions which weaken their body immunity...

Gilead drug remdesivir improves 68% COVID-19 patients: Study

New York, April 12 (IANS) Treatment with Gilead Sciences's experimental drug remdesivir led to clinical improvement in 68 per cent of 53 patients hospitalised...